|
1/5/2026
|
VENU
|
Finke Thomas M |
17.04%
|
P Purchase (Open Market or Private)
|
|
$34,016 |
+4,361 |
29,961 |
$7.80 |
Director |
CONSUMER CYCLICAL |
$400,767,936 |
18.97%
|
|
|
1/5/2026
|
NNUP
|
Westenburg Kevin Camerer |
19.94%
|
A Grant, Award, or Other Acquisition
|
Award Stock granted as compensation (RSUs, ESPP, etc.)
|
$50,000 |
+33,333 |
200,533 |
$1.50 |
President |
|
$0 |
N/A
|
|
|
1/5/2026
|
CPAY
|
Stull Steven T |
29.10%
|
P Purchase (Open Market or Private)
|
|
$2,519,840 |
+8,000 |
35,488 |
$314.98 |
Director |
TECHNOLOGY |
$23,408,541,000 |
4.88%
|
|
|
1/5/2026
|
PLD
|
Connor James B. |
-100.00%
|
S Sale (Open Market)
|
Award Stock granted as compensation (RSUs, ESPP, etc.)
|
$10,126,544 |
-80,000 |
0 |
$126.58 |
Director |
REAL ESTATE |
$120,195,389,800 |
-2.35%
|
|
|
1/2/2026
|
AVAH
|
Cunningham Patrick A. |
-10.93%
|
S Sale (Open Market)
|
10b5-1 Pre-arranged trading plan that provides insider trading defense
|
$292,488 |
-36,015 |
293,354 |
$8.12 |
Chief Compliance Officer |
HEALTHCARE |
$1,794,545,490 |
-6.31%
|
|
|
1/2/2026
|
AVAH
|
Buckhalter Matthew |
-10.83%
|
S Sale (Open Market)
|
10b5-1 Pre-arranged trading plan that provides insider trading defense
|
$431,054 |
-53,077 |
436,980 |
$8.12 |
Chief Financial Officer |
HEALTHCARE |
$1,794,545,490 |
-6.31%
|
|
|
1/2/2026
|
CYTK
|
Callos Andrew |
-3.44%
|
M Exercise or Conversion of Derivative Security
|
10b5-1 Pre-arranged trading plan that provides insider trading defense
Exercise Conversion of stock options into actual shares
|
$112,585 |
-1,798 |
50,440 |
$62.62 |
EVP, Chief Commercial Officer |
HEALTHCARE |
$7,479,759,070 |
-1.26%
|
|
|
1/2/2026
|
AVAH
|
Stewart Deborah |
-12.09%
|
S Sale (Open Market)
|
10b5-1 Pre-arranged trading plan that provides insider trading defense
|
$281,126 |
-34,616 |
251,676 |
$8.12 |
SVP, Chief Accounting Officer |
HEALTHCARE |
$1,794,545,490 |
-6.31%
|
|
|
1/2/2026
|
PATH
|
Dines Daniel |
-0.12%
|
S Sale (Open Market)
|
10b5-1 Pre-arranged trading plan that provides insider trading defense
|
$737,307 |
-45,000 |
38,048,882 |
$16.38 |
CEO and Chairman |
TECHNOLOGY |
$7,402,246,080 |
-2.77%
|
|
|
1/2/2026
|
JANX
|
DiRaimondo Thomas |
-1.58%
|
A Grant, Award, or Other Acquisition
|
Award Stock granted as compensation (RSUs, ESPP, etc.)
|
$34,394 |
-2,505 |
155,825 |
$13.73 |
Chief Scientific Officer |
|
$0 |
-3.74%
|
|
|
1/2/2026
|
ORKA
|
Sandler Laura Lee |
-5.96%
|
M Exercise or Conversion of Derivative Security
|
10b5-1 Pre-arranged trading plan that provides insider trading defense
Exercise Conversion of stock options into actual shares
|
$370,795 |
-13,000 |
205,084 |
$28.52 |
Chief Operating Officer |
|
$0 |
1.45%
|
|
|
1/2/2026
|
FG
|
Blunt Christopher O |
0.45%
|
J Other Acquisition or Disposition
|
|
$147,800 |
+5,000 |
1,117,396 |
$29.56 |
Chief Executive Officer |
FINANCIAL SERVICES |
$3,871,158,750 |
-4.29%
|
|
|
1/2/2026
|
JANX
|
Dobek Maria |
-4.09%
|
A Grant, Award, or Other Acquisition
|
Award Stock granted as compensation (RSUs, ESPP, etc.)
|
$20,073 |
-1,462 |
34,308 |
$13.73 |
Vice President, Accounting |
|
$0 |
-3.74%
|
|
|
1/2/2026
|
CPNG
|
Lee Jonathan D. |
-2.15%
|
S Sale (Open Market)
|
|
$63,278 |
-2,679 |
122,096 |
$23.62 |
Chief Accounting Officer |
CONSUMER CYCLICAL |
$37,868,057,880 |
2.70%
|
|
|
1/2/2026
|
AVAH
|
Reisz Edwin C. |
-3.71%
|
S Sale (Open Market)
|
10b5-1 Pre-arranged trading plan that provides insider trading defense
|
$413,942 |
-50,970 |
1,321,114 |
$8.12 |
Chief Administrative Officer |
HEALTHCARE |
$1,794,545,490 |
-6.31%
|
|
|
1/2/2026
|
JANX
|
Winter Charles M. |
-2.21%
|
A Grant, Award, or Other Acquisition
|
Award Stock granted as compensation (RSUs, ESPP, etc.)
|
$32,966 |
-2,401 |
106,321 |
$13.73 |
Chief Technical Officer |
|
$0 |
-3.74%
|
|
|
1/2/2026
|
AI
|
Ehikian Stephen Bradley |
-56.28%
|
A Grant, Award, or Other Acquisition
|
Gift Shares transferred as a gift to another party
Award Stock granted as compensation (RSUs, ESPP, etc.)
|
$3,185,488 |
-234,918 |
182,488 |
$13.56 |
Chief Executive Officer |
TECHNOLOGY |
$1,883,587,000 |
-1.96%
|
|
|
1/2/2026
|
YELP
|
Saldanha Craig |
-0.62%
|
S Sale (Open Market)
|
10b5-1 Pre-arranged trading plan that provides insider trading defense
|
$36,516 |
-1,200 |
192,079 |
$30.43 |
Chief Product Officer |
COMMUNICATION SERVICES |
$1,945,431,850 |
-2.15%
|
|
|
1/2/2026
|
UWMC
|
Mat Ishbia; SFS... |
-22.36%
|
C Conversion of Derivative Security
|
10b5-1 Pre-arranged trading plan that provides insider trading defense
Conversion Conversion of derivative securities into common stock
|
$8,366,594 |
-1,898,622 |
6,594,112 |
$4.41 |
President and CEO |
FINANCIAL SERVICES |
$1,171,883,600 |
-21.54%
|
|
|
1/2/2026
|
CPT
|
WEBSTER STEVEN A |
-0.13%
|
M Exercise or Conversion of Derivative Security
|
Exercise Conversion of stock options into actual shares
|
$16,814 |
-154 |
118,820 |
$109.18 |
Director |
REAL ESTATE |
$11,625,606,400 |
1.24%
|
|
|
1/2/2026
|
UTHR
|
MAHON PAUL A |
-18.41%
|
M Exercise or Conversion of Derivative Security
|
10b5-1 Pre-arranged trading plan that provides insider trading defense
Exercise Conversion of stock options into actual shares
|
$4,029,076 |
-8,300 |
36,781 |
$485.43 |
EVP & GENERAL COUNSEL |
HEALTHCARE |
$20,806,240,818 |
2.72%
|
|
|
1/2/2026
|
CURI
|
Hayden Phillip Brady |
-12.12%
|
S Sale (Open Market)
|
10b5-1 Pre-arranged trading plan that provides insider trading defense
|
$65,662 |
-17,474 |
126,667 |
$3.76 |
Chief Financial Officer |
COMMUNICATION SERVICES |
$205,072,200 |
5.85%
|
|
|
1/2/2026
|
XENE
|
MORTIMER IAN |
-66.33%
|
M Exercise or Conversion of Derivative Security
|
10b5-1 Pre-arranged trading plan that provides insider trading defense
Exercise Conversion of stock options into actual shares
|
$1,777,093 |
-40,000 |
20,300 |
$44.43 |
PRESIDENT & CEO |
HEALTHCARE |
$3,257,141,250 |
5.26%
|
|
|
1/2/2026
|
CNO
|
Bhojwani Gary C. |
-3.64%
|
S Sale (Open Market)
|
10b5-1 Pre-arranged trading plan that provides insider trading defense
|
$1,319,639 |
-31,430 |
831,397 |
$41.99 |
Chief Executive Officer |
FINANCIAL SERVICES |
$4,206,848,800 |
-2.84%
|
|
|
1/2/2026
|
ALKS
|
Hopkinson Craig C. |
-6.08%
|
S Sale (Open Market)
|
10b5-1 Pre-arranged trading plan that provides insider trading defense
|
$112,000 |
-4,000 |
61,740 |
$28.00 |
EVP R&D, Chief Medical Officer |
HEALTHCARE |
$4,897,399,880 |
-4.95%
|
|
|
1/2/2026
|
AVAH
|
Shaner Jeff |
-3.43%
|
S Sale (Open Market)
|
10b5-1 Pre-arranged trading plan that provides insider trading defense
|
$689,985 |
-84,960 |
2,394,179 |
$8.12 |
Chief Executive Officer |
HEALTHCARE |
$1,794,545,490 |
-6.31%
|
|
|
1/2/2026
|
JANX
|
McIver Zachariah |
-4.93%
|
A Grant, Award, or Other Acquisition
|
Award Stock granted as compensation (RSUs, ESPP, etc.)
|
$37,263 |
-2,714 |
52,286 |
$13.73 |
Chief Medical Officer |
|
$0 |
-3.74%
|
|
|
1/2/2026
|
BUKS
|
Daly Joseph Patrick |
0.03%
|
P Purchase (Open Market or Private)
|
|
$8,141 |
+2,678 |
8,855,000 |
$3.04 |
Director |
|
$0 |
N/A
|
|
|
1/2/2026
|
MAX
|
Yeh Kuanling Amy |
-0.75%
|
S Sale (Open Market)
|
10b5-1 Pre-arranged trading plan that provides insider trading defense
|
$38,850 |
-3,000 |
396,662 |
$12.95 |
Chief Technology Officer |
|
$659,675,447 |
2.93%
|
|
|
1/2/2026
|
JANX
|
Meyer Andrew Hollman |
-2.21%
|
S Sale (Open Market)
|
|
$25,799 |
-1,879 |
83,095 |
$13.73 |
Chief Business Officer |
|
$0 |
-3.74%
|
|
|
1/2/2026
|
CLNN
|
Ugwumba Chidozie |
-2.18%
|
S Sale (Open Market)
|
|
$99,088 |
-17,110 |
766,480 |
$5.79 |
10% Owner |
CONSUMER DEFENSIVE |
$64,397,650 |
-10.83%
|
|
|
1/2/2026
|
OMF
|
Shulman Douglas H. |
-24.83%
|
S Sale (Open Market)
|
10b5-1 Pre-arranged trading plan that provides insider trading defense
|
$3,933,790 |
-57,500 |
174,100 |
$68.41 |
President & CEO |
FINANCIAL SERVICES |
$8,344,844,160 |
-2.62%
|
|
|
1/2/2026
|
ZS
|
BEER JAMES A |
-15.78%
|
S Sale (Open Market)
|
10b5-1 Pre-arranged trading plan that provides insider trading defense
|
$148,048 |
-653 |
3,485 |
$226.72 |
Director |
TECHNOLOGY |
$34,308,575,730 |
1.74%
|
|
|
1/2/2026
|
MPWR
|
Lee Victor K |
-2.10%
|
S Sale (Open Market)
|
10b5-1 Pre-arranged trading plan that provides insider trading defense
|
$558,516 |
-600 |
27,967 |
$930.86 |
Director |
TECHNOLOGY |
$45,939,457,850 |
-2.42%
|
|
|
1/2/2026
|
HOWL
|
EVNIN LUKE |
-3.07%
|
S Sale (Open Market)
|
10b5-1 Pre-arranged trading plan that provides insider trading defense
|
$48,431 |
-78,377 |
2,472,297 |
$0.62 |
Director |
HEALTHCARE |
$27,597,452 |
6.41%
|
|
|
1/2/2026
|
JCTC
|
OREGON COMMUNITY FOUNDATION |
-0.48%
|
S Sale (Open Market)
|
|
$9,091 |
-4,006 |
838,534 |
$2.27 |
10% Owner |
|
$0 |
-1.05%
|
|
|
1/2/2026
|
FBRX
|
Riley Antony A |
30.19%
|
F Payment of Exercise Price or Tax Withholding
|
Exercise Conversion of stock options into actual shares
Tax Shares withheld to cover tax obligations
|
$254,833 |
+9,680 |
41,741 |
$26.33 |
CHIEF FINANCIAL OFFICER |
HEALTHCARE |
$296,897,652 |
N/A
|
|
|
1/2/2026
|
UWHR
|
DICK ROGER L |
0.85%
|
P Purchase (Open Market or Private)
|
|
$9,734 |
+889 |
105,272 |
$10.95 |
President/CEO of UCC |
|
$0 |
N/A
|
|
|
1/2/2026
|
FGBI
|
Smith Edgar R. III |
4.19%
|
P Purchase (Open Market or Private)
|
|
$1,128,578 |
+208,996 |
5,191,301 |
$5.40 |
Director |
FINANCIAL SERVICES |
$116,682,040 |
41.53%
|
|
|
1/2/2026
|
JOBY
|
Thompson Michael N. Jr. |
0.01%
|
P Purchase (Open Market or Private)
|
|
$14,564 |
+1,100 |
18,684,568 |
$13.24 |
Director |
INDUSTRIALS |
$13,713,351,840 |
16.59%
|
|
|
1/2/2026
|
ALSN
|
Coll John |
-8.64%
|
S Sale (Open Market)
|
10b5-1 Pre-arranged trading plan that provides insider trading defense
|
$176,933 |
-1,791 |
18,927 |
$98.79 |
SVP, Global MSS |
CONSUMER CYCLICAL |
$8,676,623,250 |
-6.49%
|
|
|
1/2/2026
|
RCG
|
STAHL MURRAY |
1.83%
|
P Purchase (Open Market or Private)
|
|
$2,971 |
+1,134 |
63,268 |
$2.62 |
President/Co-Portfolio Manager |
|
$0 |
0.39%
|
|
|
1/2/2026
|
MPB
|
Abel Robert A |
0.04%
|
P Purchase (Open Market or Private)
|
|
$496 |
+16 |
36,717 |
$31.02 |
Director |
FINANCIAL SERVICES |
$725,734,800 |
1.55%
|
|
|
1/2/2026
|
UUU
|
AULT MILTON C III |
2.33%
|
P Purchase (Open Market or Private)
|
|
$20,070 |
+4,060 |
178,657 |
$4.94 |
Director |
INDUSTRIALS |
$11,657,016 |
-2.33%
|
|
|
1/2/2026
|
PCVX
|
Dhaliwal Harpreet S. |
-28.94%
|
S Sale (Open Market)
|
|
$454,891 |
-9,743 |
23,928 |
$46.69 |
Chief Technical Ops Officer |
HEALTHCARE |
$5,978,349,150 |
0.20%
|
|
|
1/2/2026
|
MPB
|
MOWERY THEODORE W |
0.10%
|
P Purchase (Open Market or Private)
|
|
$1,985 |
+64 |
64,513 |
$31.02 |
Director |
FINANCIAL SERVICES |
$725,734,800 |
1.55%
|
|
|
1/2/2026
|
LOCL
|
Nordby Matthew |
-0.97%
|
S Sale (Open Market)
|
10b5-1 Pre-arranged trading plan that provides insider trading defense
|
$2,137 |
-1,000 |
101,705 |
$2.14 |
Director |
CONSUMER DEFENSIVE |
$49,555,520 |
-4.67%
|
|
|
1/2/2026
|
VRDN
|
Tousignant Jennifer |
-100.00%
|
S Sale (Open Market)
|
|
$70,796 |
-2,272 |
0 |
$31.16 |
Chief Legal Officer |
HEALTHCARE |
$2,955,702,750 |
-2.02%
|
|
|
1/2/2026
|
KEQU
|
HULL THOMAS DAVID III |
-1.84%
|
S Sale (Open Market)
|
|
$24,790 |
-658 |
35,177 |
$37.67 |
President, CEO |
CONSUMER CYCLICAL |
$107,463,750 |
-0.24%
|
|
|
1/2/2026
|
ARQT
|
Burnett Patrick |
-1.73%
|
S Sale (Open Market)
|
10b5-1 Pre-arranged trading plan that provides insider trading defense
|
$49,560 |
-1,697 |
96,610 |
$29.20 |
See Remarks |
HEALTHCARE |
$3,456,724,240 |
2.82%
|
|
|
1/2/2026
|
RDGL
|
Korenko Michael K |
1.86%
|
P Purchase (Open Market or Private)
|
|
$12,920 |
+200,000 |
10,935,090 |
$0.06 |
CEO AND PRESIDENT |
|
$0 |
N/A
|
|
|
1/2/2026
|
CGC
|
Yanofsky Theresa |
-14.11%
|
S Sale (Open Market)
|
|
$11,790 |
-10,434 |
63,518 |
$1.13 |
Director |
HEALTHCARE |
$383,748,930 |
-7.89%
|
|
|
1/2/2026
|
AUUD
|
Thramann Jeffrey John |
-49.41%
|
S Sale (Open Market)
|
|
$2,197 |
-2,301 |
2,356 |
$0.96 |
CEO and Executive Chairman |
|
$0 |
N/A
|
|
|
1/2/2026
|
TRAK
|
FIELDS RANDALL K |
-0.15%
|
S Sale (Open Market)
|
10b5-1 Pre-arranged trading plan that provides insider trading defense
|
$92,587 |
-7,500 |
4,858,107 |
$12.34 |
CHIEF EXECUTIVE OFFICER |
TECHNOLOGY |
$211,910,401 |
6.31%
|
|
|
1/2/2026
|
ADMQ
|
Johnson Marc |
0.34%
|
P Purchase (Open Market or Private)
|
|
$10,104 |
+210,500 |
61,319,438 |
$0.05 |
CEO |
|
$0 |
N/A
|
|
|
1/2/2026
|
CRWV
|
McBee Brannin |
-15.76%
|
M Exercise or Conversion of Derivative Security
|
Exercise Conversion of stock options into actual shares
|
$4,182,723 |
-57,636 |
307,964 |
$72.57 |
Chief Development Officer |
TECHNOLOGY |
$29,119,830,680 |
-11.91%
|
|
|
1/2/2026
|
VEL
|
Taylor Jeffrey T. |
-1.89%
|
S Sale (Open Market)
|
10b5-1 Pre-arranged trading plan that provides insider trading defense
|
$61,388 |
-3,049 |
158,672 |
$20.13 |
Executive VP, Capital Markets |
FINANCIAL SERVICES |
$715,726,732 |
10.31%
|
|
|
1/2/2026
|
PB
|
HOLMES NED S |
-0.86%
|
S Sale (Open Market)
|
10b5-1 Pre-arranged trading plan that provides insider trading defense
|
$76,314 |
-1,100 |
127,110 |
$69.38 |
Director |
FINANCIAL SERVICES |
$6,887,942,430 |
-4.92%
|
|
|
1/2/2026
|
ONFO
|
Wells Dominic... |
6.39%
|
P Purchase (Open Market or Private)
|
|
$49,713 |
+74,500 |
1,240,000 |
$0.67 |
CEO, CRO, Chair of Board |
|
$0 |
N/A
|
|
|
1/2/2026
|
CRWV
|
Venturo Brian M |
-9.03%
|
M Exercise or Conversion of Derivative Security
|
Exercise Conversion of stock options into actual shares
|
$4,785,363 |
-65,940 |
663,919 |
$72.57 |
Chief Strategy Officer |
TECHNOLOGY |
$29,119,830,680 |
-11.91%
|
|
|
1/2/2026
|
MPB
|
Evans Albert J. |
0.77%
|
P Purchase (Open Market or Private)
|
|
$10,019 |
+323 |
42,456 |
$31.02 |
Director |
FINANCIAL SERVICES |
$725,734,800 |
1.55%
|
|
|
1/2/2026
|
GPUS
|
AULT MILTON C III;... |
N/A
|
P Purchase (Open Market or Private)
|
|
$298,862 |
+1,608,833 |
N/A |
$0.19 |
Executive Chairman |
INDUSTRIALS |
$112,724,179 |
89.60%
|
|
|
1/2/2026
|
MPB
|
Frank Joel L. |
0.72%
|
P Purchase (Open Market or Private)
|
|
$2,482 |
+80 |
11,238 |
$31.02 |
Director |
FINANCIAL SERVICES |
$725,734,800 |
1.55%
|
|
|
1/2/2026
|
TPL
|
HORIZON KINETICS... |
0.00%
|
P Purchase (Open Market or Private)
|
|
$288 |
+1 |
3,487,779 |
$287.54 |
10% Owner |
|
$7,166,588,597 |
8.58%
|
|
|
1/2/2026
|
PCOK
|
Hall Keith D |
-100.00%
|
J Other Acquisition or Disposition
|
|
$0 |
-901,509 |
0 |
N/A |
Chief Executive Officer |
|
$0 |
N/A
|
|
|
1/2/2026
|
CGC
|
Lazzarato David Angelo |
-15.20%
|
S Sale (Open Market)
|
|
$17,758 |
-15,715 |
87,672 |
$1.13 |
Director |
HEALTHCARE |
$383,748,930 |
-7.89%
|
|
|
1/2/2026
|
FGBI
|
REYNOLDS MARSHALL T |
2.24%
|
P Purchase (Open Market or Private)
|
|
$250,004 |
+46,297 |
2,109,968 |
$5.40 |
Director |
FINANCIAL SERVICES |
$116,682,040 |
41.53%
|
|
|
1/2/2026
|
LSAK
|
Mazanderani Ali |
342.78%
|
P Purchase (Open Market or Private)
|
|
$9,000,000 |
+1,800,000 |
2,325,115 |
$5.00 |
Executive Chairman |
TECHNOLOGY |
$394,363,340 |
-1.68%
|
|
|
1/2/2026
|
CRWV
|
Intrator Michael N |
-100.00%
|
C Conversion of Derivative Security
|
10b5-1 Pre-arranged trading plan that provides insider trading defense
Exercise Conversion of stock options into actual shares
Conversion Conversion of derivative securities into common stock
|
$11,662,514 |
-161,427 |
0 |
$72.25 |
CEO and President |
TECHNOLOGY |
$29,119,830,680 |
-11.91%
|
|
|
1/2/2026
|
ACT
|
Genworth Holdings, Inc. |
-0.78%
|
S Sale (Open Market)
|
|
$35,863,960 |
-908,673 |
115,223,783 |
$39.47 |
10% Owner |
FINANCIAL SERVICES |
$5,979,893,240 |
-2.27%
|
|
|
1/2/2026
|
CSAI
|
Bentley Sheldon Richard |
-33.33%
|
S Sale (Open Market)
|
10b5-1 Pre-arranged trading plan that provides insider trading defense
|
$42,000 |
-50,000 |
100,000 |
$0.84 |
Founder |
TECHNOLOGY |
$13,353,124 |
-18.28%
|
|
|
1/2/2026
|
MNTR
|
Billingsley Chester |
0.06%
|
P Purchase (Open Market or Private)
|
|
$168 |
+2,000 |
3,156,296 |
$0.08 |
Chief Executive Officer |
|
$0 |
N/A
|
|
|
1/2/2026
|
CWAN
|
Cox James S |
-1.72%
|
M Exercise or Conversion of Derivative Security
|
Exercise Conversion of stock options into actual shares
|
$141,106 |
-5,859 |
334,061 |
$24.08 |
Chief Financial Officer |
TECHNOLOGY |
$6,947,968,070 |
-0.04%
|
|
|
1/2/2026
|
CWAN
|
Das Souvik |
-4.97%
|
M Exercise or Conversion of Derivative Security
|
Exercise Conversion of stock options into actual shares
|
$126,993 |
-5,273 |
100,756 |
$24.08 |
Chief Technology Officer |
TECHNOLOGY |
$6,947,968,070 |
-0.04%
|
|
|
1/2/2026
|
ZLAB
|
Amado Rafael |
-17.07%
|
M Exercise or Conversion of Derivative Security
|
Exercise Conversion of stock options into actual shares
|
$188,039 |
-10,787 |
52,391 |
$17.43 |
See Remarks |
|
$0 |
-5.16%
|
|
|
1/2/2026
|
MPB
|
De Soto Matthew G |
0.22%
|
P Purchase (Open Market or Private)
|
|
$7,972 |
+257 |
118,499 |
$31.02 |
Director |
FINANCIAL SERVICES |
$725,734,800 |
1.55%
|
|
|
1/2/2026
|
MPB
|
Brumbaugh Kimberly J |
0.60%
|
P Purchase (Open Market or Private)
|
|
$2,482 |
+80 |
13,486 |
$31.02 |
Director |
FINANCIAL SERVICES |
$725,734,800 |
1.55%
|
|
|
1/2/2026
|
LTC
|
BOITANO DAVID M |
64.00%
|
P Purchase (Open Market or Private)
|
|
$344,400 |
+10,000 |
25,626 |
$34.44 |
EVP & CIO |
|
$0 |
N/A
|
|
|
1/2/2026
|
PHIO
|
Bitterman Robert J |
1.75%
|
P Purchase (Open Market or Private)
|
|
$5,150 |
+5,000 |
291,421 |
$1.03 |
Chairman, Pres. & CEO |
|
$0 |
10.48%
|
|
|
1/2/2026
|
PCOK
|
McMillan Peter |
-100.00%
|
J Other Acquisition or Disposition
|
|
$0 |
-901,509 |
0 |
N/A |
See Remarks |
|
$0 |
N/A
|
|
|
1/2/2026
|
BXMT
|
Pena Fernando Austin |
-3.83%
|
S Sale (Open Market)
|
10b5-1 Pre-arranged trading plan that provides insider trading defense
|
$60,234 |
-3,131 |
78,633 |
$19.24 |
President |
REAL ESTATE |
$3,262,231,800 |
-1.67%
|
|
|
1/2/2026
|
MONIX
|
Meli Ali |
-2.12%
|
P Purchase (Open Market or Private)
|
|
$256,400 |
-25,614 |
1,184,331 |
$10.01 |
President and CEO |
|
$0 |
N/A
|
|
|
1/2/2026
|
RH
|
DEMILIO MARK S |
-1.59%
|
S Sale (Open Market)
|
|
$164,068 |
-900 |
55,858 |
$182.30 |
Director |
CONSUMER CYCLICAL |
$4,105,176,900 |
-22.24%
|
|
|
1/2/2026
|
RCUS
|
Goeltz II Robert C. |
-8.80%
|
S Sale (Open Market)
|
10b5-1 Pre-arranged trading plan that provides insider trading defense
|
$153,186 |
-6,552 |
67,924 |
$23.38 |
Chief Financial Officer |
HEALTHCARE |
$2,556,370,740 |
11.83%
|
|
|
1/2/2026
|
INTU
|
COOK SCOTT D |
-0.02%
|
S Sale (Open Market)
|
10b5-1 Pre-arranged trading plan that provides insider trading defense
|
$936,564 |
-1,402 |
5,668,182 |
$668.02 |
Director |
TECHNOLOGY |
$180,358,954,500 |
2.34%
|
|
|
1/2/2026
|
HQI
|
Hermanns Richard |
0.33%
|
P Purchase (Open Market or Private)
|
|
$99,757 |
+9,704 |
2,951,283 |
$10.28 |
President and CEO |
|
$0 |
5.10%
|
|
|
1/2/2026
|
KEYS
|
YOON SUNG |
-5.13%
|
G Gift of Securities
|
Gift Shares transferred as a gift to another party
|
$183,678 |
-888 |
16,453 |
$206.66 |
SVP |
TECHNOLOGY |
$35,625,748,800 |
-0.63%
|
|
|
1/2/2026
|
JOBY
|
Allison Eric |
-4.69%
|
S Sale (Open Market)
|
|
$429,936 |
-32,448 |
659,980 |
$13.25 |
Chief Product Officer |
INDUSTRIALS |
$13,713,351,840 |
-16.41%
|
|
|
1/2/2026
|
PTCT
|
Klein Matthew B. |
-2.31%
|
S Sale (Open Market)
|
10b5-1 Pre-arranged trading plan that provides insider trading defense
|
$619,941 |
-8,089 |
341,875 |
$76.64 |
CHIEF EXECUTIVE OFFICER |
HEALTHCARE |
$6,158,828,140 |
-1.76%
|
|
|
1/2/2026
|
ANNX
|
Carson William H. |
8.18%
|
P Purchase (Open Market or Private)
|
10b5-1 Pre-arranged trading plan that provides insider trading defense
|
$20,657 |
+4,115 |
54,405 |
$5.02 |
Director |
HEALTHCARE |
$576,906,750 |
4.17%
|
|
|
1/2/2026
|
CRMD
|
DUNTON ALAN W |
-33.20%
|
M Exercise or Conversion of Derivative Security
|
10b5-1 Pre-arranged trading plan that provides insider trading defense
Exercise Conversion of stock options into actual shares
|
$260,000 |
-20,000 |
40,250 |
$13.00 |
Director |
HEALTHCARE |
$597,802,870 |
38.86%
|
|
|
1/2/2026
|
AGIO
|
Goff Brian |
-11.56%
|
M Exercise or Conversion of Derivative Security
|
10b5-1 Pre-arranged trading plan that provides insider trading defense
Exercise Conversion of stock options into actual shares
|
$506,664 |
-18,703 |
143,103 |
$27.09 |
Chief Executive Officer |
HEALTHCARE |
$1,656,700,740 |
-3.95%
|
|
|
1/2/2026
|
AGIO
|
Burns James William |
-8.46%
|
M Exercise or Conversion of Derivative Security
|
10b5-1 Pre-arranged trading plan that provides insider trading defense
Exercise Conversion of stock options into actual shares
|
$79,428 |
-2,932 |
31,718 |
$27.09 |
Chief Legal Officer |
HEALTHCARE |
$1,656,700,740 |
-3.95%
|
|
|
1/2/2026
|
CME
|
SHEPARD WILLIAM R |
0.10%
|
P Purchase (Open Market or Private)
|
|
$73,008 |
+262 |
258,710 |
$278.37 |
Director |
FINANCIAL SERVICES |
$94,638,682,650 |
-4.85%
|
|
|
1/2/2026
|
NUVL
|
Noci Darlene |
-7.69%
|
M Exercise or Conversion of Derivative Security
|
10b5-1 Pre-arranged trading plan that provides insider trading defense
Exercise Conversion of stock options into actual shares
|
$400,179 |
-4,000 |
48,034 |
$100.04 |
Chief Development Officer |
HEALTHCARE |
$7,066,818,550 |
-4.65%
|
|
|
1/2/2026
|
RNXT
|
Agah Ramtin |
0.03%
|
P Purchase (Open Market or Private)
|
|
$169 |
+205 |
778,665 |
$0.83 |
Chief Medical Officer |
HEALTHCARE |
$41,043,408 |
28.06%
|
|
|
1/2/2026
|
UA
|
WATSA V PREM ET... |
N/A
|
P Purchase (Open Market or Private)
|
|
$67,443,913 |
+13,182,469 |
N/A |
$5.12 |
10% Owner |
CONSUMER CYCLICAL |
$1,122,226,560 |
10.75%
|
|
|
1/2/2026
|
AEF
|
Clark Anthony S. |
N/A
|
P Purchase (Open Market or Private)
|
|
$10,798 |
+1,500 |
1,500 |
$7.20 |
Director |
|
$0 |
2.22%
|
|
|
1/2/2026
|
GLSI
|
Patel Snehal |
0.05%
|
P Purchase (Open Market or Private)
|
|
$63,017 |
+2,900 |
5,595,102 |
$21.73 |
CEO and CFO |
HEALTHCARE |
$344,573,984 |
15.33%
|
|
|
1/2/2026
|
ONTF
|
Vattuone Steven |
-15.02%
|
S Sale (Open Market)
|
10b5-1 Pre-arranged trading plan that provides insider trading defense
|
$638,744 |
-80,000 |
452,654 |
$7.98 |
Chief Financial Officer |
TECHNOLOGY |
$336,758,148 |
1.24%
|
|